Kyverna Therapeutics Files $300M Mixed Securities Shelf Offering

viernes, 27 de marzo de 2026, 11:05 am ET1 min de lectura
KYTX--

Kyverna Therapeutics has filed a $300M mixed securities shelf, allowing the company to offer and sell various securities, including common or preferred stock, either individually or in combination, in one or more offerings. Debt securities may also be converted to common stock.

Kyverna Therapeutics Files $300M Mixed Securities Shelf Offering

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios